Dr. Marie McNeelyDysfunction in the homeostasis of iron and other elements likely contributes to the development of Parkinson's disease (PD), and Dr. Paul Lingor is working to identify patterns of bioelements in CSF that could be used as biomarkers. He is also studying tear fluid as a potential biomarker source and is involved in studying PD therapies, including the drug Fasudil as well as combinations of advanced therapies for people with later-stage PD. Learn more about his work in our latest podcast episode!
#Parkinsons #ParkinsonsDisease #ParkinsonsResearch #Neuroscience #Neurology #Biomarkers #Biomarker #Diagnostics #ClinicalTrials #AdvancedTherapies #Research #MJFF
Episode 20: Studying CSF Element Profiles and Tear Fluid as Potential Biomarkers, and Novel and Combined Therapies for PD with Paul Lingor
Dr. Paul Lingor discusses his work in this area to identify patterns of bioelements in CSF that could serve as Parkinson's disease biomarkers.
Charlie McHenry